Recent Topics in the Pathophysiology and Medical Management of Inflammatory Bowel Disease

被引:0
作者
Esaki, Motohiro [1 ]
Saruta, Masayuki [2 ]
机构
[1] Saga Univ, Dept Internal Med, Div Gastroenterol, Fac Med, Saga, Japan
[2] Jikei Univ, Dept Internal Med, Div Gastroenterol & Hepatol, Sch Med, Tokyo, Japan
关键词
ULCERATIVE-COLITIS;
D O I
10.1159/000526304
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
引用
收藏
页码:5 / 6
页数:2
相关论文
共 7 条
  • [1] 5-aminosalicylate-intolerant patients are at increased risk of colectomy for ulcerative colitis
    Hibiya, Shuji
    Matsuyama, Yusuke
    Fujii, Toshimitsu
    Maeyashiki, Chiaki
    Saito, Eiko
    Ito, Kimiko
    Shimizu, Hiromichi
    Kawamoto, Ami
    Motobayashi, Maiko
    Takenaka, Kento
    Nagahori, Masakazu
    Kurosaki, Masayuki
    Yauchi, Tsunehito
    Ohtsuka, Kazuo
    Fujiwara, Takeo
    Okamoto, Ryuichi
    Watanabe, Mamoru
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2021, 53 (01) : 103 - 113
  • [2] Discontinuation of infliximab in patients with ulcerative colitis in remission (HAYABUSA): a multicentre, open-label, randomised controlled trial
    Kobayashi, Taku
    Motoya, Satoshi
    Nakamura, Shiro
    Yamamoto, Takayuki
    Nagahori, Masakazu
    Tanaka, Shinji
    Hisamatsu, Tadakazu
    Hirai, Fumihito
    Nakase, Hiroshi
    Watanabe, Kenji
    Matsumoto, Takayuki
    Tanaka, Masanori
    Abe, Takayuki
    Suzuki, Yasuo
    Watanabe, Mamoru
    Hibi, Toshifumi
    [J]. LANCET GASTROENTEROLOGY & HEPATOLOGY, 2021, 6 (06): : 429 - 437
  • [3] SCENIC International Consensus Statement on Surveillance and Management of Dysplasia in Inflammatory Bowel Disease
    Laine, Loren
    Kaltenbach, Tonya
    Barkun, Alan
    McQuaid, Kenneth R.
    Subramanian, Venkataraman
    Soetikno, Roy
    [J]. GASTROENTEROLOGY, 2015, 148 (03) : 639 - +
  • [4] Anti-tumor necrosis factor therapy decreases the risk of initial intestinal surgery after diagnosis of Crohn's disease of inflammatory type
    Nagata, Yutaka
    Esaki, Motohiro
    Moriyama, Tomohiko
    Hirano, Atsushi
    Umeno, Junji
    Maehata, Yuji
    Torisu, Takehiro
    Matsumoto, Takayuki
    Kitazono, Takanari
    [J]. JOURNAL OF GASTROENTEROLOGY, 2019, 54 (04) : 330 - 338
  • [5] The incidence rate of colectomy for medically refractory ulcerative colitis has declined in parallel with increasing anti-TNF use: a time-trend study
    Reich, K. M.
    Chang, H-J.
    Rezaie, A.
    Wang, H.
    Goodman, K. J.
    Kaplan, G. G.
    Svenson, L. W.
    Lees, G.
    Fedorak, R. N.
    Kroeker, K. I.
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2014, 40 (06) : 629 - 638
  • [6] Dysbiosis in Inflammatory Bowel Disease: Pathogenic Role and Potential Therapeutic Targets
    Santana, Patricia Teixeira
    Bittencourt Rosas, Siane Lopes
    Ribeiro, Beatriz Elias
    Marinho, Ygor
    de Souza, Heitor S. P.
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (07)
  • [7] STRIDE-II: An Update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) Initiative of the International Organization for the Study of IBD (IOIBD): Determining Therapeutic Goals for Treat-to-Target strategies in IBD
    Turner, Dan
    Ricciuto, Amanda
    Lewis, Ayanna
    D'Amico, Ferdinando
    Dhaliwal, Jasbir
    Griffiths, Anne M.
    Bettenworth, Dominik
    Sandborn, William J.
    Sands, Bruce E.
    Reinisch, Walter
    Schoelmerich, Juergen
    Bemelman, Willem
    Danese, Silvio
    Mary, Jean Yves
    Rubin, David
    Colombel, Jean-Frederic
    Peyrin-Biroulet, Laurent
    Dotan, Iris
    Abreu, Maria T.
    Dignass, Axel
    [J]. GASTROENTEROLOGY, 2021, 160 (05) : 1570 - 1583